HC Wainwright Trims Gamida Cell (NASDAQ:GMDA) Target Price to $5.00

Gamida Cell (NASDAQ:GMDA – Free Report) had its target price cut by HC Wainwright from $11.00 to $5.00 in a research report report published on Wednesday, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Gamida Cell’s Q4 2023 earnings at ($0.13) EPS, FY2023 earnings at ($0.66) […]

Leave a Reply

Your email address will not be published.

Previous post HC Wainwright Raises Legend Biotech (NASDAQ:LEGN) Price Target to $87.00
Next post Icosavax (NASDAQ:ICVX) Stock Rating Reaffirmed by William Blair